Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway
2014 ◽
Vol 11
(2)
◽
pp. 1516-1522
◽
2010 ◽
Vol 2010
◽
pp. 337-339